Cardiovascular diseases (CVD) are responsible for a substantial portion of global health issues, with rising numbers of cases in both developed and developing nations. The challenges associated with CVD are multifaceted, involving a complex interplay of genetic, environmental, and socioeconomic factors. In many regions, limited access to quality healthcare and the increasing prevalence of risk factors like obesity, diabetes, and smoking contribute to the growing burden of heart disease. Tackling these global cardiovascular challenges demands innovative public health strategies that emphasize prevention, equitable access to care, and the education of populations about the importance of lifestyle modifications. Efforts at a global level to address these issues will play a key role in reducing the impact of CVD on health systems worldwide.
Title : Personalized and precision medicine (PPM) as a unique healthcare model through biodesign-driven translational applications and cardiology-related healthcare marketing to secure the human healthcare and biosafety
Sergey Suchkov, N.D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences, Russian Federation
Title : Beyond weight loss and diabetes control GLP 1 agonists paradigm shift in Cardiovascular care .
Syed Raza, Awali Hospital, Bahrain
Title : Vericiguat Inhibits the Progress of Cardiac Hypertrophy and Prevents Hypertrophy Induced Heart Failure by Multiple Mechanisms
Guo Wei He, TEDA International Cardiovascular Hospital, Tianjin University, China
Title : Therapeutic pneumoperitoneum mimicking inferior myocardial infarction and right ventricular aneurysm: A case report
Abhinav Prithvi Venkata Sesha Kanigicherla, University Hospital Coventry and Warwickshire NHS Trust, United Kingdom
Title : Multisystem IgG4-related disease with cardiac involvement mimicking cardiac sarcoidosis: a diagnostic challenge background
Natasha Manuelpillai, Salisbury District Hospital- NHS, United Kingdom
Title : Coronary revascularization in patients with diabetes: Prospects for stenting in patients with type 1 diabetes and coronary artery disease
Mekhman N Mamedov, National Research Center for Therapy and Preventive Medicine, Russian Federation